NCT07558239Not yet recruiting
Carotid Intima-media Thickness in Dialysis Patients and Traditional Risk Factors
Association of Traditional Cardiovascular and Dialysis-Specific Risk Factors With Carotid Intima-Media Thickness in Hemodialysis Patients: A Cross-Sectional Study"
Source: ClinicalTrials.gov · Last updated 30 Apr 2026
Brief summary (registry, in English)
* Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD) patients. * Carotid intima-media thickness (CIMT) is a validated surrogate marker for atherosclerosis. * Both traditional cardiovascular risk factors (hypertension, diabetes, dyslipidemia) and dialysis-specific factors (mineral metabolism disorders, dialysis duration) contribute to vascular damage.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 23 Apr 2026
- Start date
- 24 Apr 2026
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Minia University
- Diseases
- High blood pressure
- NCT number
- NCT07558239
What you commit to
- Study type: Observational
- Planned participants: 100
- From 24 Apr 2026 to the primary completion date, 1 Jul 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- o Active malignancy
- Acute infections
- Recent cardiovascular events (\<3 months)
- Poor echocardiographic window for CIMT measurement
Who the study is looking for
- 1\. Age 18 or older. 2. Patients with sepsis without AKI at the time of admission.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.